Prilosec OTC Sales Top The $400 Mil. Mark; Prevacid Feeling The Burn
This article was originally published in The Tan Sheet
Executive Summary
Abbott says that Prilosec OTC continues to eat into Prevacid sales and the overall prescription proton pump inhibitor category after one year on the market
You may also be interested in...
TAP Licenses Prevacid To Novartis For 2009 Switch
Novartis is developing TAP's Prevacid prescription heartburn and GERD therapy for a 2009 switch to OTC status, the firms announced Dec. 20
TAP Licenses Prevacid To Novartis For 2009 Switch
Novartis is developing TAP's Prevacid prescription heartburn and GERD therapy for a 2009 switch to OTC status, the firms announced Dec. 20
TAP Licenses Prevacid To Novartis For 2009 Switch
Novartis is developing TAP's Prevacid prescription heartburn and GERD therapy for a 2009 switch to OTC status, the firms announced Dec. 20